米国の細胞培養市場規模、シェア、動向分析レポート：製品別、用途別、セグメント予測、2024年～2030年

米国の細胞培養市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、米国の細胞培養市場規模は2030年までに109億7,000万米ドルに達すると予測され、2024年から2030年までのCAGRは10.02％で成長すると予測されています。

市場成長の原動力は、バイオシミラーや生物製剤の成長、幹細胞研究の進展、細胞由来ワクチンの開発を促進するバイオ製造技術の出現など、さまざまな要因にあると見られています。

COVID-19の大流行により、信頼性の高い細胞ベースのワクチン製造技術に対する需要が高まっています。さらに、特にワクチン技術の開発と試験において、いくつかの注目すべき科学的ブレークスルーをもたらしました。2021年8月、ダナハーはCytivaとPallの製造拡大を発表し、COVIDの医薬品とワクチン開発を支援し、パンデミック時の需要に対応するために細胞培養や遺伝子治療など様々な様式の製造拡大を可能にしました。

細胞培養技術はここ数年で大きな進歩を遂げ、その応用範囲は急速に拡大しています。バイオ医薬品の分野では、哺乳類細胞の培養が可能になったことで、複雑なタンパク質ベースの医薬品を大量に生産できるようになった。このことは、バイオ医薬品業界における効率の向上、コストの削減、品質管理の改善につながっています。さらに、高収率細胞株の上市と培養条件の最適化が、生産性とスケーラビリティの向上に寄与しています。例えば2023年6月、マティカ・バイオ社はBIO国際大会でMatiMax細胞株を発表しました。この細胞株は、処理期間を短縮するために倍加時間を短縮し、トランスフェクション効率を向上させ、低コストで力価を増加させることができるのが特徴です。

しかし、ライフサイエンス産業で使用される動物や動物由来製品の倫理的意味をめぐる認識や議論の高まりは、市場の成長をある程度妨げています。動物が飼育される条件や処置中に引き起こされる可能性のある苦痛から、動物個体群への全体的な影響に至るまで、懸念が高まっています。しかし、無血清・無タンパク培地製品のイントロダクションは、こうした制約を克服すると期待されています。

米国の細胞培養市場レポート・ハイライト

• 消耗品セグメントは2023年に58.0%の最大収益シェアで市場をリードし、予測期間中に最も速いCAGRで成長すると予測されます。この背景には、モノクローナル抗体やワクチンなどの高度な生物製剤を開発するために、バイオテクノロジーやバイオ医薬品企業が研究開発費を増大させていることがあります。
• 用途別では、バイオ医薬品製造分野が2023年に31.9%の最大収益シェアで市場をリードし、予測期間中に最も速いCAGRで成長すると予想されます。二重特異性抗体、抗体フラグメント、抗体誘導体の開発など、抗体治療薬の技術的進歩は、細胞培養の用途の市場展望を拡大すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数と傾向

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助市場見通し
• 市場力学
  • 市場 促進要因分析
  • 市場抑制要因分析
• 業界分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 製品ビジネス分析

• 製品セグメントダッシュボード
• 米国の細胞培養市場の製品変動分析
• 米国の細胞培養市場規模と動向分析、製品別、2018～2030年
• 消耗品
  • 消耗品市場推計・予測、2018年-2030年
  • 血清
  • 試薬
  • 培地
• 機器
  • 機器市場推計・予測、2018年-2030年
  • 培養システム
  • インキュベーター
  • 遠心分離機
  • 冷凍保存装置
  • バイオセーフティ機器
  • ピペッティング

第5章 用途ビジネス分析

• 用途セグメントダッシュボード
• 米国の細胞培養市場の用途変動分析
• 米国の細胞培養市場の規模と動向分析、用途別、2018～2030年
• バイオ医薬品製造
  • バイオ医薬品生産市場推計・予測、2018年-2030年
  • モノクローナル抗体
  • ワクチン製造
  • その他の治療用タンパク質
• 医薬品開発
• 診断
• 組織培養とエンジニアリング
• 細胞・遺伝子治療
• 毒性試験
• その他の用途

第6章 競合情勢

• 企業分類
• 戦略マッピング
• 企業市況分析、2023年
• 企業プロファイル/上場企業
  • Sartorius AG
  • Danaher
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Corning Inc.
  • Avantor Inc.
  • BD
  • Eppendorf SE
  • Bio-Techne
  • PromoCell GmbH

List of Tables

• Table 1 List of abbreviation
• Table 2 List of secondary sources
• Table 3 U.S. cell culture market, by product, 2018 - 2030 (USD Million)
• Table 4 U.S. cell culture market, by application, 2018 - 2030 (USD Million)
• Table 5 Key companies undergoing expansions
• Table 6 Key companies undergoing acquisitions
• Table 7 Key companies undergoing collaborations
• Table 8 Key companies launching new products
• Table 9 Key companies undertaking other strategies

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Market formulation & validation
• Fig. 6 U.S. cell culture market: market outlook
• Fig. 7 U.S. cell culture competitive insights
• Fig. 8 Parent market outlook
• Fig. 9 U.S. cell culture market driver impact
• Fig. 10 U.S. cell culture market restraint impact
• Fig. 11 U.S. cell culture market: Product movement analysis
• Fig. 12 U.S. cell culture market: Product outlook and key takeaways
• Fig. 13 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 14 Sera market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 15 Fetal bovine serum market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 16 Other market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 17 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 Albumin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Media market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Serum-free media market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 CHO media market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 HEK 293 media market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 BHK medium market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Vero medium market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Other serum-free media market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Classical media market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Stem cell culture media market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Chemically defined media market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Specialty media market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Other cell culture media market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Culture systems market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Incubators market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Centrifuges market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Cryostorage equipment market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Biosafety equipment market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Pipetting market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 U.S cell culture market: Application movement analysis
• Fig. 40 U.S cell culture market: Application outlook and key takeaways
• Fig. 41 Biopharmaceutical production market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 Vaccines production market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Other therapeutic proteins market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Drug development market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 Tissue culture & engineering market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Cell & gene therapy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Toxicity testing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 50 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 Market positioning of key market players - U.S cell culture market

U.S. Cell Culture Market Growth & Trends:

The U.S. cell culture market size is anticipated to reach USD 10.97 billion by 2030 and is projected to grow at a CAGR of 10.02% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is expected to be driven by various factors, such as the growth of biosimilars and biologics, advancements in stem cell research, and the emergence of bio-manufacturing technologies that facilitate the development of cell-based vaccines.

The COVID-19 pandemic has resulted in an increased demand for reliable cell-based vaccine production technologies. Furthermore, it has led to a few notable scientific breakthroughs, particularly in the development and testing of vaccine technologies. In August 2021, Danaher announced the manufacturing expansion of Cytiva and Pall which assisted in the drug and vaccine development for COVID and enabled expansion in manufacturing of various modalities such as cell culture and gene therapy to meet the demands during the pandemic.

Cell culture technology has witnessed significant advancements over the past few years and the technology is witnessing a rapid expansion in its scope of applications. In the field of biopharmaceuticals, researchers can now produce complex protein-based drugs in large quantities due to the ability to culture mammalian cells. This has led to increased efficiency, reduced costs, and improved quality control in the biopharmaceutical industry. Furthermore, the launch of high-yield cell lines and the optimization of culture conditions have contributed to enhanced productivity and scalability. For instance, in June 2023, Matica Bio launched its MatiMax cell lines at the BIO International Convention. The cell line features faster doubling times to reduce processing timelines, has enhanced transfection efficiencies, and enables increased titer production at a lower cost.

However, the growing awareness and debate surrounding the ethical implications of animals and animal-based products used in the life sciences industry is impeding market growth to a certain extent. Concerns ranging from conditions in which animals are housed and potential pain caused during procedures to the overall impact on the animal population are growing. However, the introduction of serum-free, protein-free media products is expected to overcome these limitations.

U.S. Cell Culture Market Report Highlights:

• The consumables segment led the market with the largest revenue share of 58.0% in 2023 and are expected to grow at the fastest CAGR during the forecast period. This is attributed to the increased R&D expenditure by biotechnology & biopharmaceutical businesses to develop sophisticated biologics, such as monoclonal antibodies & vaccines
• Based on application, the biopharmaceutical production segment led the market with the largest revenue share of 31.9% in 2023 and is expected to grow at the fastest CAGR during the forecast period. The technological advancements in antibody therapeutics, such as the development of bispecific antibodies, antibody fragments, and antibody derivatives, are anticipated to expand the market prospects for applications of cell culture

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Product Segment
  • 1.1.2. Application Segment
• 1.2. Estimates and Forecast Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Primary Research
• 1.5. Information or Data Analysis:
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. Objective

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables &Trends

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Expansion in the scope of applications for cell culture technology
    • 3.2.1.2. Rising demand for biopharmaceuticals, artificial organs, & vaccine production
    • 3.2.1.3. Growth in demand for serum-free, specialty, and customized media
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Stringent process control in cell culture techniques
    • 3.2.2.2. Scalability issues with culturing methods
    • 3.2.2.3. Ethical concerns regarding the use of animals
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. U.S. Cell Culture Market Product Movement Analysis
• 4.3. U.S. Cell Culture Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Consumables
  • 4.4.1. Consumables market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Sera
    • 4.4.2.1. Sera market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2.2. Fetal Bovine Serum
    • 4.4.2.2.1. Fetal bovine serum market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2.3. Other
    • 4.4.2.3.1. Other market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Reagents
    • 4.4.3.1. Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3.2. Albumin
    • 4.4.3.2.1. Albumin market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3.3. Other
    • 4.4.3.3.1. Other market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Media
    • 4.4.4.1. Media market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4.2. Serum-free Media
    • 4.4.4.2.1. Serum-free media market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4.2.2. CHO Media
    • 4.4.4.2.2.1. CHO media market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4.2.3. HEK 293 Media
    • 4.4.4.2.3.1. HEK 293 media market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4.2.4. BHK Medium
    • 4.4.4.2.4.1. BHK medium market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4.2.5. Vero Medium
    • 4.4.4.2.5.1. Vero medium market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4.2.6. Other Serum-free Media
    • 4.4.4.2.6.1. Other serum-free media market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4.3. Classical Media
    • 4.4.4.3.1. Classical media market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4.4. Stem Cell Culture Media
    • 4.4.4.4.1. Stem cell culture media market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4.5. Chemically Defined Media
    • 4.4.4.5.1. Chemically defined media market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4.6. Specialty Media
    • 4.4.4.6.1. Specialty media market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4.7. Other Cell Culture Media
    • 4.4.4.7.1. Other cell culture media market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.5. Instruments
  • 4.5.1. Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Culture Systems
    • 4.5.2.1. Culture systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Incubators
    • 4.5.3.1. Incubators market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Centrifuges
    • 4.5.4.1. Centrifuges market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.5. Cryostorage Equipment
    • 4.5.5.1. Cryostorage equipment market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.6. Biosafety Equipment
    • 4.5.6.1. Biosafety equipment market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.7. Pipetting
    • 4.5.7.1. Pipetting market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

• 5.1. Application Segment Dashboard
• 5.2. U.S. Cell Culture Market Application Movement Analysis
• 5.3. U.S. Cell Culture Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Biopharmaceutical Production
  • 5.4.1. Biopharmaceutical production market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. Monoclonal Antibodies
    • 5.4.2.1. Monoclonal antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.3. Vaccine Production
    • 5.4.3.1. Vaccine production market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.4. Other Therapeutic Proteins
    • 5.4.4.1. Other therapeutic proteins market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.5. Drug Development
  • 5.5.1. Drug development market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.6. Diagnostics
  • 5.6.1. Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.7. Tissue Culture and Engineering
  • 5.7.1. Tissue culture and engineering market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.8. Cell & Gene Therapy
  • 5.8.1. Cell & gene therapy market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.9. Toxicity Testing
  • 5.9.1. Toxicity testing market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.10. Other Application
  • 5.10.1. Other applications market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Company Categorization
• 6.2. Strategy Mapping
• 6.3. Company Market Position Analysis, 2023
• 6.4. Company Profiles/Listing
  • 6.4.1. Sartorius AG
    • 6.4.1.1. Overview
    • 6.4.1.2. Financial Performance
    • 6.4.1.3. Product Benchmarking
    • 6.4.1.4. Strategic Initiatives
  • 6.4.2. Danaher
    • 6.4.2.1. Overview
    • 6.4.2.2. Financial Performance
    • 6.4.2.3. Product Benchmarking
    • 6.4.2.4. Strategic Initiatives
  • 6.4.3. Merck KGaA
    • 6.4.3.1. Overview
    • 6.4.3.2. Financial Performance
    • 6.4.3.3. Product Benchmarking
    • 6.4.3.4. Strategic Initiatives
  • 6.4.4. Thermo Fisher Scientific, Inc.
    • 6.4.4.1. Overview
    • 6.4.4.2. Financial Performance
    • 6.4.4.3. Product Benchmarking
    • 6.4.4.4. Strategic Initiatives
  • 6.4.5. Corning Inc.
    • 6.4.5.1. Overview
    • 6.4.5.2. Financial Performance
    • 6.4.5.3. Product Benchmarking
    • 6.4.5.4. Strategic Initiatives
  • 6.4.6. Avantor Inc.
    • 6.4.6.1. Overview Avantor Inc.
    • 6.4.6.2. Financial Performance
    • 6.4.6.3. Product Benchmarking
    • 6.4.6.4. Strategic Initiatives
  • 6.4.7. BD
    • 6.4.7.1. Overview
    • 6.4.7.2. Financial Performance
    • 6.4.7.3. Product Benchmarking
    • 6.4.7.4. Strategic Initiatives
  • 6.4.8. Eppendorf SE
    • 6.4.8.1. Overview
    • 6.4.8.2. Financial Performance
    • 6.4.8.3. Product Benchmarking
    • 6.4.8.4. Strategic Initiatives
  • 6.4.9. Bio-Techne
    • 6.4.9.1. Overview
    • 6.4.9.2. Financial Performance
    • 6.4.9.3. Product Benchmarking
    • 6.4.9.4. Strategic Initiatives
  • 6.4.10. PromoCell GmbH
    • 6.4.10.1. Overview
    • 6.4.10.2. Financial Performance
    • 6.4.10.3. Product Benchmarking
    • 6.4.10.4. Strategic Initiatives